← All news

FROM THE NEWS FEED

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

2026-09-01 • Psychedelic Invest

Article summary

CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for…

Continue to the original publication for the complete article.